focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUPP.L Regulatory News (SUPP)

  • There is currently no data for SUPP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asset Sale

1 Dec 2021 13:00

RNS Number : 0381U
Schroder UK Public Private Tst plc
01 December 2021
 

Schroder UK Public Private Trust plc

Asset Sale

 

Schroder UK Public Private Trust plc (the "Company") notes that Seedrs has entered into an agreement to be acquired by Republic, the U.S. based private investment platform, for approximately $100 million in a mix of shares, cash and carried interest1 (the "Republic Acquisition").

The Republic Acquisition is subject to the consent of the Financial Conduct Authority ("FCA") and shareholders of Seedrs, and is expected to be completed in early 2022.

The Company is pleased to announce that it has reached an agreement for the sale of its holding in Seedrs Limited ("Seedrs") to a global institutional investment management firm, for £12 million in cash ("Asset Sale"). The consideration is payable on completion, which is subject to consent of the FCA. The Asset Sale is expected to complete in early 2022, in advance of the Republic Acquisition.

The Asset Sale is not conditional on the Republic Acquisition, and provides a full exit from the Company's position for cash while also expediting the receipt of the proceeds for reinvestment in new opportunities. The Company intends to use the net proceeds of the Asset Sale to accelerate its portfolio rebalancing with new investments into both public and private companies.

On the basis of the terms of the Asset Sale, the Company's AIFM has increased the valuation of the holding in Seedrs by 29.7% from £9.1 million as at 30 June 2021 to £11.8 million as at 30 September 2021.

 

1 This part of the consideration is related to the "carry" fee" that Seedrs earns when investors sell the securities previously purchased through Seedrs at a profit which will be carved out of the transaction and paid to existing Seedrs shareholders and optionholders as it crystallizes in the future. 

Enquiries:

Schroder Investment Management Limited

Estelle Bibby (Press)

0207 658 3431

Gareth Faith (Company Secretary)

020 7658 5264

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISURRARAOUAOAA
Date   Source Headline
9th Dec 202210:34 amRNSNet Asset Value(s)
8th Dec 202210:54 amRNSNet Asset Value(s)
7th Dec 20224:47 pmRNSTransaction in Own Shares
7th Dec 202210:51 amRNSNet Asset Value(s)
6th Dec 202210:47 amRNSNet Asset Value(s)
5th Dec 202210:40 amRNSNet Asset Value(s)
2nd Dec 202210:46 amRNSNet Asset Value(s)
1st Dec 202211:51 amRNSNet Asset Value(s)
30th Nov 20225:24 pmRNSTotal Voting Rights
30th Nov 202210:39 amRNSNet Asset Value(s)
29th Nov 20225:10 pmRNSTransaction in Own Shares
29th Nov 202210:52 amRNSNet Asset Value(s)
28th Nov 202210:56 amRNSNet Asset Value(s)
25th Nov 202210:58 amRNSNet Asset Value(s)
24th Nov 202211:49 amRNSNet Asset Value(s)
23rd Nov 20224:56 pmRNSTransaction in Own Shares
23rd Nov 202210:39 amRNSNet Asset Value(s)
22nd Nov 202211:30 amRNSNet Asset Value(s)
21st Nov 202211:17 amRNSNet Asset Value(s)
18th Nov 202211:24 amRNSNet Asset Value(s)
17th Nov 20224:55 pmRNSTransaction in Own Shares
17th Nov 202211:13 amRNSNet Asset Value(s)
17th Nov 20227:00 amRNSInvestment in A2 Biotherapeutics
16th Nov 202211:01 amRNSNet Asset Value(s)
15th Nov 202211:23 amRNSNet Asset Value(s)
14th Nov 202211:32 amRNSNet Asset Value(s)
11th Nov 202211:32 amRNSNet Asset Value(s)
10th Nov 202211:35 amRNSNet Asset Value(s)
9th Nov 20224:40 pmRNSSecond Price Monitoring Extn
9th Nov 20224:35 pmRNSPrice Monitoring Extension
9th Nov 202211:46 amRNSNet Asset Value(s)
8th Nov 202211:41 amRNSNet Asset Value(s)
7th Nov 20224:54 pmRNSTransaction in Own Shares
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Nov 202211:51 amRNSNet Asset Value(s)
4th Nov 20225:58 pmRNSTransaction in Own Shares
4th Nov 20224:41 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 202211:53 amRNSNet Asset Value(s)
4th Nov 20227:00 amRNSInvestment in iOnctura
3rd Nov 20225:09 pmRNSTransaction in Own Shares
3rd Nov 202211:23 amRNSNet Asset Value(s)
2nd Nov 20225:43 pmRNSTransaction in Own Shares
2nd Nov 202211:06 amRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
1st Nov 202211:16 amRNSNet Asset Value(s)
31st Oct 20225:30 pmRNSTotal Voting Rights
31st Oct 20225:17 pmRNSTransaction in Own Shares
31st Oct 202211:31 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.